Evaluation of Troponin T Criteria for Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndromes

In patients with acute coronary syndromes undergoing percutaneous coronary intervention (PCI), the diagnosis of periprocedural myocardial infarction is often problematic when the pre-PCI levels of cardiac troponin T (TnT) are elevated. Thus, we examined different TnT criteria for periprocedural myocardial infarction when the pre-PCI TnT levels were elevated and also the associations between the post-PCI cardiac marker levels and outcomes. We established the relation between the post-PCI creatine kinase-MB (CKMB) and TnT levels in 582 patients (315 with acute coronary syndromes and 272 with stable coronary heart disease). A post-PCI increase in the CKMB levels to 14.7 mu g/L (3 x the upper reference limit [URL] in men) corresponded to a TnT of 0.23 mu g/L. In the 85 patients with acute coronary syndromes and normal CKMB, but elevated post peak TnT levels before PCI (performed at a median of 5 days, interquartile range 3 to 7), the post-PCI cardiac marker increases were as follows: 21(24.7%) with a >= 20% increase in TnT, 10(11.8%) with an CKMB level > 3 x URL, and 12 (14%) with an absolute TnT increase of > 0.09 mu g/L (p < 0.005 for both). In the patients with stable coronary heart disease and post-PCI cardiac markers > 3 x URL compared to those without markers elevations, the rate of freedom from death or nonfatal myocardial infarction was 88% for those with TnT elevations versus 99% (p < 0.001, log-rank) and 84% for those with CKMB elevations versus 98% (p < 0.001, log-rank). Of the patients with acute coronary syndromes, the post-PCI marker levels did not influence the outcomes. In conclusion, in patients with acute coronary syndromes and elevated TnT levels undergoing PCI several days later >= 20% increases in TnT were more common than absolute increments in the TnT or CKMB levels of > 3 x URL. Also, periprocedural cardiac marker elevations in patients with acute coronary syndromes did not have prognostic significance. (C) 2011 Elsevier Inc. All rights reserved. (Am J Cardiol 2011;107:863 870)